نتائج البحث 61-70 من 3068 لعملية البحث عن ���������������������������op������r���:za33���
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
... (R/R) multiple myeloma (MM). Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study.
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
New to Mayo Clinic Connect? Connect with thousands of patients and caregivers for support, practical information, and answers. Hosted and moderated by Mayo ...
... (R/R) multiple myeloma (MM). Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL ...
Rochester, Minn. The purpose of this study is to evaluate long-term symptom resolution and quality of life improvements after operative management of popliyteal ...
... (R/R) chronic lymphocytic leukemia (CLL). Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors. Scottsdale/Phoenix, Ariz ...
... (R/M SGC). Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary Cancer and Changes in Gut Microbiome. Scottsdale/Phoenix, Ariz ...
There are few studies using prehabilitation to improve peri-operative outcomes in patients undergoing cancer surgery. This study will pilot a program of ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.